Bayer Aktiengesellschaft (OTCMKTS:BAYRY) issued an update on its FY 2021 earnings guidance on Tuesday morning. The company provided EPS guidance of $7.660-$7.900 for the period. The company issued revenue guidance of $51.89 billion-$51.89 billion, compared to the consensus revenue estimate of $51.41 billion.
OTCMKTS:BAYRY traded down $0.41 during mid-day trading on Thursday, hitting $13.39. 617,463 shares of the company’s stock traded hands, compared to its average volume of 457,803. The company has a debt-to-equity ratio of 1.20, a quick ratio of 0.80 and a current ratio of 1.16. The firm’s 50 day simple moving average is $13.97 and its 200 day simple moving average is $14.74. Bayer Aktiengesellschaft has a 1 year low of $13.10 and a 1 year high of $17.34. The company has a market cap of $52.60 billion, a PE ratio of 267.75, a price-to-earnings-growth ratio of 2.01 and a beta of 1.23.
Several equities research analysts have issued reports on BAYRY shares. Berenberg Bank decreased their price target on shares of Bayer Aktiengesellschaft from €74.00 ($84.09) to €60.00 ($68.18) and set a buy rating on the stock in a research note on Monday, August 9th. AlphaValue raised shares of Bayer Aktiengesellschaft to a buy rating in a research note on Monday, November 15th. JPMorgan Chase & Co. reaffirmed an overweight rating on shares of Bayer Aktiengesellschaft in a research note on Wednesday, November 10th. Morgan Stanley reissued an overweight rating on shares of Bayer Aktiengesellschaft in a research report on Wednesday, November 10th. Finally, Kepler Capital Markets reissued a buy rating on shares of Bayer Aktiengesellschaft in a research report on Friday, October 29th. Five research analysts have rated the stock with a hold rating and eight have given a buy rating to the stock. According to data from MarketBeat.com, Bayer Aktiengesellschaft has a consensus rating of Buy and a consensus price target of $39.00.
Bayer AG engages in the development, manufacture and distribution of products in the areas of health care, nutrition and high-tech materials. It operates through the following segments: Pharmaceuticals, Consumer Health, Crop Science, Animal Health and Covestro. The Pharmaceuticals segment engages in the development, production and marketing of prescription products for cardiology and women’s health care; specialty therapeutics in the areas of oncology, hematology and ophthalmology; diagnostic imaging equipment and the necessary contrast agents.
Further Reading: What is a back-end load?
Receive News & Ratings for Bayer Aktiengesellschaft Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bayer Aktiengesellschaft and related companies with MarketBeat.com's FREE daily email newsletter.